The mission of the NCI’s Office of Cancer Genomics (OCG) is to enhance understanding of the molecular mechanisms of cancer, with the ultimate goal of improving the prevention, early detection, diagnosis, and treatment of cancer. Learn More
The Cancer Genome Anatomy Project (CGAP)
CGAP is an online resource designed to characterize biological tissues and provide
cDNA clones to the research community....more
The NIH Mammalian Gene Collection (MGC)
The goal of MGC is to provide full-length open reading frame (FL-ORF) clones for
human, mouse, and rat genes....more
The Initiative for Chemical Genetics (ICG)
The ICG provides a systematic approach to study biology using such small molecules,
to develop new screening tools and compounds, and to accelerate the development
of new cancer strategies and therapies....more
The Cancer Genome Atlas (TCGA)
TCGA is a collaborative effort between the NCI and the NHGRI that will test the
feasibility of a large-scale systematic approach to identify genetic alterations
in human cancer....more
Cancer Genetic Markers of Susceptibility (CGEMS)
CGEMS is an NCI enterprise initiative to conduct whole-genome association studies
to identify genes giving rise to risk of prostate and breast cancer....more
Therapeutically Applicable Research to Generate
Effective Treatments (TARGET)
The TARGET Initiative seeks to harness the power of modern genomics technologies
to rapidly identify valid therapeutic targets in childhood cancers so that new,
more effective treatments can be developed....more
NCI Announces New Funding to Support TCGA Genome Characterization Centers and Genome Data Analysis Centers
TCGA
January 8, 2009
TARGET Study Finds Predictor of Relapse for Acute Lymphoblastic Leukemia
TARGET
January 7, 2009
The Cancer Genome Atlas Reports First Results of Comprehensive Study of Brain Tumors
TCGA
September 4, 2008
Summary CGEMS GWAS results are temporarily unavailable for public posting; individual level data still available
CGEMS
August 28, 2008
Click here to read past news.
For more information about funding available through the Office of Cancer Genomics, click here.